Literature DB >> 21239650

Creutzfeldt-Jacob disease mimics, or how to sort out the subacute encephalopathy patient.

Katherine Murray1.   

Abstract

Sporadic Creutzfeldt-Jacob disease (CJD) is a rare untreatable neurodegenerative disease which every neurologist will occasionally encounter during their career. However, it is likely to appear on their differential diagnosis list significantly more frequently. Numerous conditions can present with subacute encephalopathy which might be sporadic CJD and this article explores these diagnoses. It includes the commonest sporadic CJD mimics which are neurodegenerative, and highlights the relatively rare treatable mimics which must not be missed. It discusses relevant investigations, including serum antibodies, CSF, electroencephalography and MR brain imaging, and strategies when preliminary investigations fail to support sporadic CJD but no alternative diagnosis is readily apparent.

Entities:  

Mesh:

Year:  2011        PMID: 21239650     DOI: 10.1136/jnnp.2010.235721

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  14 in total

Review 1.  NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease.

Authors:  Graham Mackay; Kate Ahmad; Jon Stone; Cathie Sudlow; David Summers; Richard Knight; Robert Will; Sarosh R Irani; Angela Vincent; Paul Maddison
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

Review 2.  Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.

Authors:  Michael B Coulthart; Gerard H Jansen; Neil R Cashman
Journal:  CMAJ       Date:  2014-01-20       Impact factor: 8.262

3.  Creutzfeldt-Jakob disease: The search for definitive diagnostic tests continues.

Authors:  Michael B Coulthart; Beau M Ances
Journal:  Neurol Clin Pract       Date:  2015-04

4.  Illustrating the relevance of updated diagnostic criteria for sporadic Creutzfeldt-Jakob disease: a teaching neurocase.

Authors:  Joseph Kamtchum Tatuene; Maria Isabel Vargas; Karim Burkhardt; Michel Chofflon
Journal:  BMJ Case Rep       Date:  2013-08-28

5.  Diagnosing sporadic creutzfeldt-jakob disease in a patient with a suspected status epilepticus in the intensive care unit.

Authors:  Harm J van der Horn; Peter H Egbers; Michaël A Kuiper; Wouter J Schuiling
Journal:  Case Rep Neurol Med       Date:  2013-04-04

6.  Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.

Authors:  Michael B Coulthart; Gerard H Jansen; Elina Olsen; Deborah L Godal; Tim Connolly; Bernard C K Choi; Zheng Wang; Neil R Cashman
Journal:  BMC Neurol       Date:  2011-10-27       Impact factor: 2.474

7.  EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.

Authors:  Francesca M Brett; Richard Flavin; Daphne Chen; Teresa Loftus; Seamus Looby; Allan McCarthy; Cillian de Gascun; Elaine S Jaffe; Nurul Nor; Mohsen Javadpour; Dominick McCabe
Journal:  Hum Pathol (N Y)       Date:  2017-11

8.  Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013.

Authors:  M B Coulthart; G H Jansen; T Connolly; R D'Amour; J Kruse; J Lynch; S Sabourin; Z Wang; A Giulivi; M N Ricketts; N R Cashman
Journal:  Can Commun Dis Rep       Date:  2015-08-06

9.  Symptomatic aggravation after corticosteroid pulse therapy in definite sporadic Creutzfeldt-Jakob disease with the feature of Hashimoto's encephalopathy.

Authors:  Jae-Won Jang; So Young Park; Young Ho Park; Jung E Kim; SangYun Kim
Journal:  BMC Neurol       Date:  2014-09-08       Impact factor: 2.474

10.  Endpoint Quaking-Induced Conversion: a Sensitive, Specific, and High-Throughput Method for Antemortem Diagnosis of Creutzfeldt-Jacob Disease.

Authors:  Keding Cheng; Robert Vendramelli; Angela Sloan; Brooks Waitt; Lisa Podhorodecki; Debra Godal; J David Knox
Journal:  J Clin Microbiol       Date:  2016-04-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.